CAS: 3109-99-7; 2-Fluoro-2-Methylpropan-1-Ol

该化合物其结构特征为有机化合物,包括一个带有氟原子的丙丙醇脊柱和一个附于第二碳的甲基组;该化合物由于氢氧基(OH)组与一种与另外两个碳原子相连的碳结合而被列为次要酒精;氟原子的存在具有独特的特性,例如极分性和潜在反应力,与非氟酒精相比,这可能会影响其溶解性和沸点;此类化合物通常具有中等的挥发性,并可用于各种用途,包括有机合成中的溶剂或中间体;此外,氟辛醇原子的存在可能会在特定条件下产生特定的生物活动或增强化合物的稳定性;应考虑安全因素,因为氟化合物与非氟化对应物相比,其毒性特征可能不同.

结构式图片

相似化合物

338-76-1 63812-15-7 33420-52-9

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号558-30-5 甲基环氧丙烷 | CAS号338-76-1 2-氟异丁酸甲酯

合成工艺路线路线简述

    甲基环氧丙烷置于氟化氢吡啶体系中,用 甲基叔丁基醚 用作溶剂,化学反应 19.0H,反应生成2-氟-2-甲基丙烷-1-醇
    参考文献:Process For Preparing Fluoroleucine Alkyl Esters
    标题:Process For Preparing Fluoroleucine Alkyl Esters
    摘要:这项发明涉及氟亮氨酸烷基酯的立体选择性制备.

    海关参考信息

    专利信息


    专利号:US-11897914-B2
    优先权日:2021-11-29
    标题 :Synthesis of 2′ protected nucleosides
    发明人:POON WING C; ZOU RUIMING; LAU ALDRICH N K; YU DAVID; Du Gengyu; YAO YUN-CHIAO; ZHAO GANG
    权利人:HONGENE BIOTECH CORP
    摘要:Embodiments of the present application relate to the preparation of 2′-O-protected nucleoside phosphoramidites and conjugation of the 2′-O-protected nucleoside to a solid support. More specifically, the present application relates to nucleosides having a hydroxy protecting group at the 2′ position that reduces migration to the 3′ position during RNA (e.g., mRNA) synthesis and can be readily removed under mild conditions without the use of toxic metal-containing reagents. Methods of using the nucleosides described herein in RNA synthesis are also disclosed.

    专利号:US-4255594-A
    优先权日:1979-09-18
    标题 :Hydrogenation of halogen-containing carboxylic anhydrides
    发明人:NOVOTNY MIROSLAV
    权利人:ALLIED CHEM
    摘要:A process is described for the heterogeneous hydrogenation of haloalkyl, halocycloalkyl or haloaryl carboxylic anhydrides to the corresponding primary alcohols. In the haloalkyl or halocycloalkyl carboxylic anhydrides at least one halogen is in the alpha-position relative to the carboxylic anhydride grouping. The hydrogenation can be carried out in the liquid or vapor phase in the presence of a supported or unsupported catalyst comprising a member of the group consisting of rhodium, iridium, metal oxides thereof, or mixtures thereof. In the liquid phase, the hydrogenation can be carried out batchwise under mild conditions of temperature and pressure, preferably at about 50°-150° C. and about 5-15 atmospheres, in an atmosphere containing hydrogen gas. A preferred embodiment is the hydrogenation of trifluoroacetic anhydride in the liquid phase to 2,2,2-trifluoroethanol, said alcohol being useful as an intermediate in the synthesis of the anesthetic, isoflurane, CF 3 CHClOCHF 2 .

    专利号:US-2024229131-A1
    优先权日:2022-12-22
    标 题 :Transition-metal catalyst compositions and methods for sequencing by synthesis
    发明人:MARIANI ANGELICA; BEECH TIMOTHY; FRANCAIS ANTOINE; PANIGRAHI ADYASHA; HATTINGH KATHRYN; CRESSINA ELENA
    权利人:ILLUMINA INC
    摘要:The present application relates to compositions and methods for sequencing by synthesis. A blocking group of a nucleotide may be removed by a transition metal catalyst, the transition metal catalyst activated by a non-reducing ligand and a reducing agent.

    专利号:US-2004053999-A1
    优先权日:1997-09-17
    标题 :Novel compounds and methods for synthesis and therapy
    发明人:BISCHOFBERGER NORBERT W; DAHL TERRENCE C; HITCHCOCK MICHAEL J M; KIM CHOUNG U; LEW WILLARD; LIU HONGTAO; MILLS ROGER G; WILLIAMS MATTHEW A
    摘要:Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.

    专利号:US-6225341-B1
    优先权日:1995-02-27
    标 题:Compounds and methods for synthesis and therapy
    发明人:BISCHOFBERGER NORBERT W; KIM CHOUNG U; LEW WILLARD; LIU HONGTAO; WILLIAMS MATTHEW A
    权利人:GILEAD SCIENCES INC
    摘要:Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.

    专利号:US-2024218443-A1
    优先权日:2021-05-20
    标 题:Methods of sequencing using 3' blocked nucleotides
    发明人:MARIANI ANGELICA; FRANCAIS ANTOINE; TOPPING FREDERICK JAMES; WINNARD CHRISTOPHER; BALDING PHILIP; YUN CHOL STEVEN; IAVICOLI PATRIZIA; HATTINGH KATHRYN; WU XIAOLIN; LIU XIAOHAI
    权利人:ILLUMINA INC
    摘要:The present application relates to palladium compositions, methods for sequencing by synthesis using nucleotides with 3′ blocking groups, and sequencing kits, where one or more palladium scavengers were used to improve sequencing metrics such phasing and prephasing values.
    江西科宁科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.fluopharm.com
    电话: 021-52217929 13916493875👤
    📞江西科宁科技有限公司 ⚠️参考联系方式

    销售电话:021-52217929 13916493875
    邮箱:rita.liu@fluopharm.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    常州安奈凯医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.anikare.com
    企业联系电话:0519-83598696;18018249389👤
    📞常州安奈凯医药科技有限公司 ⚠️参考联系方式
    联系人:蒋经理
    电话:0519-83598696;18018249389
    手机:18018249389
    传真:0519-83598696
    邮箱:info@anikare.com,sales@anikare.com
    通信地址: 江苏省常州市钟楼区龙城大道2239号 智谷工场
    邮编: 213018
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省常州市钟楼区龙城大道2239号 智谷工场
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    杭州氟药药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.fluoropharm.cn
    企业联系电话:0571-85586753;13336034509(微信同号)👤
    📞杭州氟药药业有限公司 ⚠️参考联系方式
    联系人:张经理
    电话:0571-85586753;13336034509(微信同号)
    手机:13336034509
    传真:询价请加QQ 2818889690 或发邮件
    邮箱:sales@fluoropharm.com
    通信地址: 浙江省杭州市滨江区西兴街道江陵路88号
    邮编: 310053
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省杭州市滨江区西兴街道江陵路88号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Haufe, G., Science of Synthesis, (2005) 34, 351.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知